Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
World Journal of Urology
|
May 9, 2021
Phase I trial of intravesical Bacillus Calmette-Guérin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette-Guérin treatment
Shaheen Alanee, Sherjeel Sana, Ahmed El-Zawahry, et al.
The New Phytologist
|
March 17, 2025
Glucosinolates can act as signals to modulate intercellular trafficking via plasmodesmata
Jessica C Fernandez, Mohammad F Azim, Nicole Adams, et al.
Eclinicalmedicine
|
July 1, 2021
HIV-1 Transmission linkages among persons with incident infection to inform public health surveillance
Ann M Dennis, Simon D W Frost, Kimberly Enders, et al.
Journal of Virology
|
March 21, 2025
Development of ferret immune repertoire reference resources and single-cell-based high-throughput profiling assays
Evan S Walsh, Kui Yang, Tammy S Tollison, et al.
Clinical Genitourinary Cancer
|
March 30, 2024
Urinary bother, Urinalysis, and Two-Year Efficacy Follow-Up Results of Phase I Trial of Intravesical Bacillus Calmette-Guérin Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-Guérin Treatment
Jazzmyne Montgomery, Daniel Lybbert, Sherjeel Sana, et al.
International Journal of Medical Informatics
|
September 24, 2025
Extracting language information from clinical notes using large language models
Lingfei Qian, Na Hong, Yujia Zhou, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
World Journal of Urology
|
May 9, 2021
Phase I trial of intravesical Bacillus Calmette-Guérin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette-Guérin treatment
Shaheen Alanee, Sherjeel Sana, Ahmed El-Zawahry, et al.
The New Phytologist
|
March 17, 2025
Glucosinolates can act as signals to modulate intercellular trafficking via plasmodesmata
Jessica C Fernandez, Mohammad F Azim, Nicole Adams, et al.
Eclinicalmedicine
|
July 1, 2021
HIV-1 Transmission linkages among persons with incident infection to inform public health surveillance
Ann M Dennis, Simon D W Frost, Kimberly Enders, et al.
Journal of Virology
|
March 21, 2025
Development of ferret immune repertoire reference resources and single-cell-based high-throughput profiling assays
Evan S Walsh, Kui Yang, Tammy S Tollison, et al.
Clinical Genitourinary Cancer
|
March 30, 2024
Urinary bother, Urinalysis, and Two-Year Efficacy Follow-Up Results of Phase I Trial of Intravesical Bacillus Calmette-Guérin Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-Guérin Treatment
Jazzmyne Montgomery, Daniel Lybbert, Sherjeel Sana, et al.
International Journal of Medical Informatics
|
September 24, 2025
Extracting language information from clinical notes using large language models
Lingfei Qian, Na Hong, Yujia Zhou, et al.
Page
of 5